@torylemoine's GLP-1 dosing explained, fact-checked

What did @torylemoine actually say?

The creator walked through how to read a GLP-1 compounded vial, explaining that the concentration printed on the label (in their case, "four milligram") is separate from the injection volume instruction. Their core message: "this is going to be what matters," pointing to the prescribed volume in mLs and its syringe equivalent in units. They also demonstrated pulling the plunger slightly past the target mark to account for an air bubble, then flicking and pushing back to clear it before landing on the correct line.

They were upfront about not being a medical professional and repeatedly directed viewers to consult their own prescribing doctor. That disclaimer matters, because this video is explicitly tagged as an ad for Amble, a telehealth platform, and reached nearly 20,000 viewers who may be self-injecting at home.

Does the science back this up?

The core claim, that mL volume is what you draw regardless of concentration, is pharmacologically correct. Compounded GLP-1 formulations, typically semaglutide or tirzepatide, vary widely in concentration between compounding pharmacies. A 4 mg/mL vial and a 1 mg/mL vial require very different draw volumes to deliver the same dose. The instruction on your specific vial label is the only reliable guide.

This confusion is not trivial. A 2023 FDA safety communication flagged multiple patient reports of dosing errors with compounded semaglutide, specifically because patients were converting between units and mLs incorrectly or misreading insulin syringe markings. U-100 insulin syringes, which most home injectors use, measure in units where 100 units equals 1 mL. So 25 units equals 0.25 mL, which matches what the creator demonstrated. That math checks out.

The air-bubble technique the creator describes is a reasonable lay approach, though clinical training typically teaches users to draw slightly over, flick, and expel the bubble before removing the needle from the vial rather than pushing medication back in. The net result is the same, but technique details matter when you are learning from a social media video rather than a nurse.

What did they get wrong (or right)?

Credit where it is due: the creator correctly identified that concentration on the vial label does not equal the dose you inject. That is probably the single most important thing a new self-injector needs to understand, and a lot of online content gets it wrong or ignores it entirely.

The earlier correction, admitting they previously told someone it was "the one milligram" when it was actually "the four milligram," is worth pausing on. That is a fourfold concentration difference. If someone had followed the wrong concentration assumption and tried to calculate their own draw volume, they could have injected four times their intended dose. The creator treats this correction as minor, but it illustrates exactly why concentration literacy matters.

The air-bubble technique is not wrong, but describing it as pulling "past the point" and then pushing back into the vial could confuse beginners about whether they are contaminating the vial or wasting medication. A cleaner explanation would help. No specific dosing recommendations were made beyond referencing their own prescription, which is appropriate.

What should you actually know?

If you are self-injecting a compounded GLP-1 at home, here is what actually matters. First, your vial label will show concentration, usually in mg/mL. Your prescription or clinical instructions will tell you the dose in mg. Those two numbers together determine your draw volume. Do not guess, and do not borrow someone else's draw volume because they are on "the same medication."

Second, most home injectors use U-100 insulin syringes. On those syringes, 1 unit equals 0.01 mL. So 25 units equals 0.25 mL. This is consistent with what the creator demonstrated. The FDA's 2023 alert specifically cited confusion between these units as a source of serious overdose events.

Third, compounded GLP-1 products are not the same as branded semaglutide or tirzepatide. They are not FDA-approved, and potency can vary by batch and compounder. Any injection tutorial, including this one, is a supplement to, not a replacement for, individualized instruction from your prescribing clinician.